<DOC>
	<DOCNO>NCT01749410</DOCNO>
	<brief_summary>This study evaluate effectiveness benefit treatment onabotulinumtoxinA Chronic Migraine patient receive minimum 7 treatment cycle .</brief_summary>
	<brief_title>A Retrospective Study Evaluate Effectiveness Benefit onabotulinumtoxinA Patients With Chronic Migraines</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>15 headache day 30 day period A minimum 7 treatment cycle onabotulinumtoxinA Any treatment cycle dose onabotulinumtoxinA great 200 unit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>